Bright Good Will vs Accounts Payable Analysis
| DRUG Stock | USD 1.10 0.03 2.65% |
Bright Minds financial indicator trend analysis is way more than just evaluating Bright Minds Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bright Minds Biosciences is a good investment. Please check the relationship between Bright Minds Good Will and its Accounts Payable accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Good Will vs Accounts Payable
Good Will vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bright Minds Biosciences Good Will account and Accounts Payable. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Bright Minds' Good Will and Accounts Payable is -0.69. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Bright Minds Biosciences, assuming nothing else is changed. The correlation between historical values of Bright Minds' Good Will and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of Bright Minds Biosciences are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Good Will i.e., Bright Minds' Good Will and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.69 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Accounts Payable
An accounting item on the balance sheet that represents Bright Minds obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bright Minds Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Bright Minds' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. The current Selling General Administrative is estimated to decrease to about 1.3 M. The current Issuance Of Capital Stock is estimated to decrease to about 1 M
Bright Minds fundamental ratios Correlations
Click cells to compare fundamentals
Bright Minds Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bright Minds fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Current Liab | 12.5K | 42K | 158.2K | 25K | 28.8K | 27.3K | |
| Total Current Liabilities | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 567.5K | |
| Total Stockholder Equity | 729.3K | 19.4M | 10.5M | 6.6M | 7.6M | 8.2M | |
| Net Debt | (799.9K) | (19.8M) | (11.5M) | (6.7M) | (6.0M) | (6.3M) | |
| Retained Earnings | (559.1K) | (9.2M) | (24.2M) | (31.5M) | (28.4M) | (27.0M) | |
| Accounts Payable | 138.4K | 596.6K | 1.2M | 182.3K | 209.7K | 199.2K | |
| Cash | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Cash And Short Term Investments | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M | |
| Liabilities And Stockholders Equity | 880.2K | 20.0M | 12.1M | 6.9M | 7.9M | 8.8M | |
| Other Stockholder Equity | 146.4K | (33.7K) | 10.5T | 831.8K | 956.6K | 908.8K | |
| Total Liab | 150.9K | 638.6K | 1.5M | 280.9K | 323.0K | 583.3K | |
| Total Current Assets | 878.2K | 20.0M | 11.9M | 6.8M | 7.8M | 8.7M | |
| Accumulated Other Comprehensive Income | 161.3K | 1.6M | 2.5M | 3.4M | 3.9M | 4.1M | |
| Common Stock | 980.7K | 27.1M | 32.2M | 33.9M | 39.0M | 20.8M |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Return On Assets (0.38) | Return On Equity (0.72) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.